in a prospective open randomized trial , pefloxacin was given to 53 patients and ceftazidime was given to 50 patients suffering from bronchopneumonia ( n = 29 ) , deep soft tissue infection ( n = 19 ) , urinary tract infection ( n = 28 ) , chronic osteomyelitis in exacerbation ( n = 15 ) , chronic otitis media in exacerbation ( n = 3 ) , malignant external otitis ( n = 3 ) , abdominal abscess ( n = 2 ) , septic arthritis ( n = 1 ) , acute cholangitis ( n = 1 ) , bacterial endocarditis ( n = 1 ) , and subacute sinusitis ( n = 1 ) .
C0007559
ceftazidime
C0042029
urinary tract infection